Botox receives FDA approval for treatment of upper limb spasticity in adults
09 March 2010 - RTTNews
Allergan Inc announced that the United States Food and Drug Administration or FDA has approved Botox for treatment of increased muscle stiffness in the elbow, wrist and fingers in adults with upper limb spasticity.
Upper limb spasticity may occur following a spinal cord or traumatic brain injury or in patients affected by multiple sclerosis or adults with a history of cerebral palsy. FDA approved the drug to treat spasticity in flexor muscles, a condition that can result from stroke, brain injury or multiple sclerosis.
"Muscles affected by spasticity have increased stiffness and tightness, which may lead to pain, difficulties with hygiene and other activities of daily living, and may affect how a patient looks," said Russell Katz, director of the FDA's division of neurology products.
Author: RTTNews
Disclaimer
This story is a transcript from the original source (indicated at the top and bottom of the article) and appears as published. It has not been edited by the MS Trust and views expressed are those of the author or originating journal. The MS Trust does not endorse the content nor any claims made.
MS Trust Information Service
For more information contact the MS Trust's personal information service on 0800 032 38 39 or by email
